000 | 01985 a2200529 4500 | ||
---|---|---|---|
005 | 20250514222923.0 | ||
264 | 0 | _c20050623 | |
008 | 200506s 0 0 eng d | ||
022 | _a1522-8002 | ||
024 | 7 |
_a10.1593/neo.04442 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFulda, Simone | |
245 | 0 | 0 |
_aSensitization for anticancer drug-induced apoptosis by betulinic Acid. _h[electronic resource] |
260 |
_bNeoplasia (New York, N.Y.) _cFeb 2005 |
||
300 |
_a162-70 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCaspases _xmetabolism |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aCisplatin _xadministration & dosage |
650 | 0 | 4 | _aComplement Membrane Attack Complex |
650 | 0 | 4 | _aComplement System Proteins |
650 | 0 | 4 |
_aCytochromes c _xmetabolism |
650 | 0 | 4 |
_aDactinomycin _xadministration & dosage |
650 | 0 | 4 |
_aDoxorubicin _xadministration & dosage |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 |
_aEnzyme Activation _xdrug effects |
650 | 0 | 4 |
_aEtoposide _xadministration & dosage |
650 | 0 | 4 |
_aFibroblasts _xdrug effects |
650 | 0 | 4 |
_aGlycoproteins _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMembrane Potentials _xdrug effects |
650 | 0 | 4 |
_aMitochondria _xdrug effects |
650 | 0 | 4 |
_aMutation _xgenetics |
650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
650 | 0 | 4 | _aPentacyclic Triterpenes |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
650 | 0 | 4 |
_aTriterpenes _xadministration & dosage |
650 | 0 | 4 | _aTumor Stem Cell Assay |
650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xmetabolism |
650 | 0 | 4 | _aBetulinic Acid |
700 | 1 | _aDebatin, Klaus-Michael | |
773 | 0 |
_tNeoplasia (New York, N.Y.) _gvol. 7 _gno. 2 _gp. 162-70 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1593/neo.04442 _zAvailable from publisher's website |
999 |
_c15472377 _d15472377 |